Pricing
Login
Home
Charts
Search
Watchlist
Products

Orchid Pharma Ltd

ORCHPHARMA
₹960.40+1.24%20 Nov 2026
Reports
Pharma API

Orchid Pharma Ltd

ORCHPHARMA
₹960.40
+1.24%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹5,751Cr
Close
Close Price
₹960.40
Industry
Industry
Pharma API
PE
Price To Earnings
134.70
PS
Price To Sales
4.71
Revenue
Revenue
₹1,221Cr
Rev Gr TTM
Revenue Growth TTM
20.13%
PAT Gr TTM
PAT Growth TTM
16.50%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
221217244223217237263298207368304341
Growth YoY
Revenue Growth YoY%
38.13.433.612.0-1.59.47.734.0-4.655.115.614.3
Expenses
ExpensesCr
185188212192191210269295206338290317
Operating Profit
Operating ProfitCr
352932302628-632301424
OPM
OPM%
16.013.313.313.612.111.8-2.11.00.88.24.67.1
Other Income
Other IncomeCr
81388841212-28218
Interest Expense
Interest ExpenseCr
434344233224
Depreciation
DepreciationCr
98899911119111111
PBT
PBTCr
303028262219-71-1225327
Tax
TaxCr
0-30000000000
PAT
PATCr
303428262219-71-1225327
Growth YoY
PAT Growth YoY%
348.6-43.4162.229.4-25.6-42.9-124.4-94.3-154.129.9137.41,704.0
NPM
NPM%
13.715.411.611.610.38.1-2.60.5-5.96.70.87.9
EPS
EPS₹
6.26.85.85.44.14.4-0.9-0.1-2.54.30.54.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
221217244223217237263298207368304341
Growth YoY
Revenue Growth YoY%
38.13.433.612.0-1.59.47.734.0-4.655.115.614.3
Expenses
ExpensesCr
185188212192191210269295206338290317
Operating Profit
Operating ProfitCr
352932302628-632301424
OPM
OPM%
16.013.313.313.612.111.8-2.11.00.88.24.67.1
Other Income
Other IncomeCr
81388841212-28218
Interest Expense
Interest ExpenseCr
434344233224
Depreciation
DepreciationCr
98899911119111111
PBT
PBTCr
303028262219-71-1225327
Tax
TaxCr
0-30000000000
PAT
PATCr
303428262219-71-1225327
Growth YoY
PAT Growth YoY%
348.6-43.4162.229.4-25.6-42.9-124.4-94.3-154.129.9137.41,704.0
NPM
NPM%
13.715.411.611.610.38.1-2.60.5-5.96.70.87.9
EPS
EPS₹
6.26.85.85.44.14.4-0.9-0.1-2.54.30.54.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
8737976836004844505606668191,3981,2331,221
Growth
Revenue Growth%
-50.0-8.8-14.3-12.2-19.4-7.024.319.023.170.6-11.820.1
Expenses
ExpensesCr
7038046676184564005065827091,2531,1991,151
Operating Profit
Operating ProfitCr
171-816-18285053841111443470
OPM
OPM%
19.6-0.92.3-3.05.811.19.512.613.510.32.75.7
Other Income
Other IncomeCr
-28-5920218241595931322926
Interest Expense
Interest ExpenseCr
294336302045132321613911
Depreciation
DepreciationCr
145141133130118109875533424342
PBT
PBTCr
-296-544-39969-70-95-5755921221042
Tax
TaxCr
-17-48-4600000-3-1000
PAT
PATCr
-279-495-35369-70-95-5755951311142
Growth
PAT Growth%
-41.6-77.528.8119.7-200.4-36.740.3197.172.138.0-91.916.5
NPM
NPM%
-32.0-62.2-51.611.6-14.4-21.2-10.28.311.69.40.93.5
EPS
EPS₹
-32.1-55.7-39.67.8-14.8-28.6-0.511.319.119.61.77.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
8737976836004844505606668191,3981,2331,221
Growth
Revenue Growth%
-50.0-8.8-14.3-12.2-19.4-7.024.319.023.170.6-11.820.1
Expenses
ExpensesCr
7038046676184564005065827091,2531,1991,151
Operating Profit
Operating ProfitCr
171-816-18285053841111443470
OPM
OPM%
19.6-0.92.3-3.05.811.19.512.613.510.32.75.7
Other Income
Other IncomeCr
-28-5920218241595931322926
Interest Expense
Interest ExpenseCr
294336302045132321613911
Depreciation
DepreciationCr
145141133130118109875533424342
PBT
PBTCr
-296-544-39969-70-95-5755921221042
Tax
TaxCr
-17-48-4600000-3-1000
PAT
PATCr
-279-495-35369-70-95-5755951311142
Growth
PAT Growth%
-41.6-77.528.8119.7-200.4-36.740.3197.172.138.0-91.916.5
NPM
NPM%
-32.0-62.2-51.611.6-14.4-21.2-10.28.311.69.40.93.5
EPS
EPS₹
-32.1-55.7-39.67.8-14.8-28.6-0.511.319.119.61.77.1
Sales CAGR
1 Year-12%
3 Years23%
5 Years22%
TTM20%
EBITDA CAGR
1 Year-77%
3 Years-26%
5 Years-8%
TTM35%
PAT CAGR
1 Year-92%
3 Years-42%
5 Years-
TTM17%
Avg. ROCE
1 Year1%
3 Years6%
5 Years5%
TTM2%
CFO / EBITDA
1 Year374%
3 Years105%
5 Years97%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
898989894141414151606060
Reserves
ReservesCr
-40-556-881-7937255445385791,0501,4941,5041,572
Current Liabilities
Current LiabilitiesCr
1,3381,5102,0132,346175142241372260509491652
Non Current Liabilities
Non Current LiabilitiesCr
2,4752,2121,9051,43651944222216512415203368
Total Liabilities
Total LiabilitiesCr
3,8623,2563,1253,0771,4601,2371,1111,2251,5542,0772,2582,652
Current Assets
Current AssetsCr
1,2516756797675695503985017911,098929955
Non Current Assets
Non Current AssetsCr
2,6112,5802,4462,3108916877137247639801,3291,697
Total Assets
Total AssetsCr
3,8623,2563,1253,0771,4601,2371,1111,2251,5542,0772,2582,652
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
898989894141414151606060
Reserves
ReservesCr
-40-556-881-7937255445385791,0501,4941,5041,572
Current Liabilities
Current LiabilitiesCr
1,3381,5102,0132,346175142241372260509491652
Non Current Liabilities
Non Current LiabilitiesCr
2,4752,2121,9051,43651944222216512415203368
Total Liabilities
Total LiabilitiesCr
3,8623,2563,1253,0771,4601,2371,1111,2251,5542,0772,2582,652
Current Assets
Current AssetsCr
1,2516756797675695503985017911,098929955
Non Current Assets
Non Current AssetsCr
2,6112,5802,4462,3108916877137247639801,3291,697
Total Assets
Total AssetsCr
3,8623,2563,1253,0771,4601,2371,1111,2251,5542,0772,2582,652

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2124019128124921812651126
Investing Cash Flow
Investing Cash FlowCr
-1-176-284516767113-31-312-36-277
Financing Cash Flow
Financing Cash FlowCr
-286-465330-250-165-217311672137
Net Cash Flow
Net Cash FlowCr
-76-2401557-2-74-1118-1917-14
Free Cash Flow
Free Cash FlowCr
211392357723238-861-102-255
CFO To PAT
CFO To PAT%
-76.0-80.9-2.617.3-115.9-24.8-162.533.2132.539.21,183.0
CFO To EBITDA
CFO To EBITDA%
124.3-5,331.458.5-66.0287.447.4174.021.9113.835.6374.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2124019128124921812651126
Investing Cash Flow
Investing Cash FlowCr
-1-176-284516767113-31-312-36-277
Financing Cash Flow
Financing Cash FlowCr
-286-465330-250-165-217311672137
Net Cash Flow
Net Cash FlowCr
-76-2401557-2-74-1118-1917-14
Free Cash Flow
Free Cash FlowCr
211392357723238-861-102-255
CFO To PAT
CFO To PAT%
-76.0-80.9-2.617.3-115.9-24.8-162.533.2132.539.21,183.0
CFO To EBITDA
CFO To EBITDA%
124.3-5,331.458.5-66.0287.447.4174.021.9113.835.6374.2

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
333233984710,0621,1601,5695,3013,9402,4265,751
Price To Earnings
Price To Earnings
0.733.957.58.873.5134.7
Price To Sales
Price To Sales
0.40.30.10.122.42.12.46.52.82.04.7
Price To Book
Price To Book
6.8-0.5-0.1-0.117.22.02.54.80.80.53.5
EV To EBITDA
EV To EBITDA
17.7-363.3151.7-101.2210.326.722.446.727.078.989.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
40.637.534.336.639.635.129.928.729.225.220.420.4
OPM
OPM%
19.6-0.92.3-3.05.811.19.512.613.510.32.75.7
NPM
NPM%
-32.0-62.2-51.611.6-14.4-21.2-10.28.311.69.40.93.5
ROCE
ROCE%
-0.1-9.1-5.44.9-5.2-4.3-2.99.28.87.91.02.4
ROE
ROE%
-569.1106.244.5-9.9-9.1-16.3-9.88.98.68.40.72.6
ROA
ROA%
-7.2-15.2-11.32.3-4.8-7.7-5.14.56.16.30.51.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
333233984710,0621,1601,5695,3013,9402,4265,751
Price To Earnings
Price To Earnings
0.733.957.58.873.5134.7
Price To Sales
Price To Sales
0.40.30.10.122.42.12.46.52.82.04.7
Price To Book
Price To Book
6.8-0.5-0.1-0.117.22.02.54.80.80.53.5
EV To EBITDA
EV To EBITDA
17.7-363.3151.7-101.2210.326.722.446.727.078.989.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
40.637.534.336.639.635.129.928.729.225.220.420.4
OPM
OPM%
19.6-0.92.3-3.05.811.19.512.613.510.32.75.7
NPM
NPM%
-32.0-62.2-51.611.6-14.4-21.2-10.28.311.69.40.93.5
ROCE
ROCE%
-0.1-9.1-5.44.9-5.2-4.3-2.99.28.87.91.02.4
ROE
ROE%
-569.1106.244.5-9.9-9.1-16.3-9.88.98.68.40.72.6
ROA
ROA%
-7.2-15.2-11.32.3-4.8-7.7-5.14.56.16.30.51.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr11,47010,2728,9845,7515,4044,9914,940
Close PriceClose₹548.201,598.60990.70960.40184.12620.1590.15
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE41.0375.8034.99134.7026.6128.1826.28
Price To SalesPS9.8011.824.164.711.965.682.16
RevenueRevenueCr1,1708692,1611,2212,7518792,286
Revenue Growth TTMRev Gr TTM%4.0%13.4%20.1%26.8%23.0%30.2%
PAT Growth TTMPAT Gr TTM%-13.6%7.1%16.5%75.4%-2.8%89.5%
Market CapitalizationMkt CapCr11,47010,2728,9845,7515,4044,9914,940
Close PriceClose₹548.201,598.60990.70960.40184.12620.1590.15
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE41.0375.8034.99134.7026.6128.1826.28
Price To SalesPS9.8011.824.164.711.965.682.16
RevenueRevenueCr1,1708692,1611,2212,7518792,286
Revenue Growth TTMRev Gr TTM%4.0%13.4%20.1%26.8%23.0%30.2%
PAT Growth TTMPAT Gr TTM%-13.6%7.1%16.5%75.4%-2.8%89.5%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Jun 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
ResultPPT
Transcript
Summary
Dec 21
Sep 21
ResultPPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Jun 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
ResultPPT
Transcript
Summary
Dec 21
Sep 21
ResultPPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews